ArticleFrontiers in systems biology2026
Multi-OCT-SelfNet: integrating self-supervised learning with multi-source data fusion for enhanced multi-class retinal disease classification.
Article in Frontiers in systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Self-Supervised OCT Representation Learning with Local Dimensionality Regularization for Automated Retinal Disease Diagnosis.Sensors (Basel, Switzerland) · 2026Article
- Deep learning-driven multi-omics analysis: enhancing cancer diagnostics and therapeutics.Briefings in bioinformatics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acquiring large and diverse medical imaging datasets remains challenging because of privacy, annotation cost, and institutional variability. This limitation can reduce the generalization ability of deep learning models, particularly when they are trained on small or domain-specific retinal datasets. To address this issue, we propose Multi-OCT-SelfNet, a self-supervised framework based on a SwinV2 transformer backbone for multi-class retinal disease classification from optical coherence tomography (OCT) images. The framework combines multi-source OCT datasets during masked autoencoder-based self-supervised pre-training to learn transferable image representations, followed by supervised fine-tuning on individual downstream datasets. We evaluated Multi-OCT-SelfNet across three benchmark OCT datasets (DS1, DS2, and DS3) and compared its performance with two baselines: ResNet-50 and traditional SwinV2 trained without the proposed self-supervised multi-source pre-training strategy. In on-domain evaluation, Multi-OCT-SelfNet-SwinV2 achieved AUC-ROC scores of 0.97 on DS1, 0.97 on DS2, and 0.89 on DS3, demonstrating competitive or improved performance compared with both baselines. The advantage of the proposed framework was more evident in cross-dataset evaluation, especially for smaller datasets. When trained on DS2 and tested on DS3, Multi-OCT-SelfNet-SwinV2 improved AUC-ROC from 0.59 with ResNet-50 and 0.61 with traditional SwinV2 to 0.90. Similarly, when trained on DS3 and tested on DS2, the proposed model achieved an AUC-ROC of 0.94, compared with 0.60 for ResNet-50 and 0.81 for traditional SwinV2. Under limited-data settings using only 50% of the training samples, Multi-OCT-SelfNet-SwinV2 maintained stronger robustness than ResNet-50, achieving AUC-ROC of 0.77 on DS2 compared with 0.68 for ResNet-50, and 0.76 on DS3 compared with 0.49 for ResNet-50. Ablation analyses further showed that multi-source data fusion and self-supervised pre-training substantially improved generalization, particularly for DS2 and DS3. Statistical evaluation using the Wilcoxon signed-rank test also supported the consistency of the proposed model's improvements across paired train-test settings. These findings suggest that Multi-OCT-SelfNet-SwinV2 can learn more transferable OCT representations than conventional supervised baselines, making it a promising approach for robust AI-assisted retinal disease classification under data-limited and domain-shifted clinical conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.